For how we live.
A prescribed home apnea test can diagnose clear-cut cases, and one under-mattress sensor flagged severe apnea with 86% sensitivity — but both miss milder disease and events a lab would catch.
Toilet seats and mirrors that read your heart and blood pressure are real engineering. The published validation is mostly small, single-lab or company-run — and outcome evidence is absent.
A meta-analysis of consumer neurofeedback found no benefit for cognition, mindfulness or physical health and only a small effect on distress — even though the headbands do record real brain activity.
Self-testing and self-managing warfarin cut clot events by roughly 40%, and self-management also lowered deaths — one of the few at-home tests with randomised evidence of real benefit.
Out-of-office readings predict heart attacks and death better than a clinic measurement, and guidelines now require them to confirm hypertension — but only a validated upper-arm cuff counts.
European hypertension specialists found only two wrist-cuff blood pressure watches with validation studies done to established protocols. A sleep group ran a Galaxy Watch against two nights of polysomnography.
Head-to-head against an ECG chest strap, popular optical wrist devices differed substantially, and one graded test found a smartwatch running a couple of beats low with a 28-bpm spread in its limits of agreement.
In a free-living comparison, three devices counted steps within about 18% of a research monitor but one overestimated active-calorie burn by 139%. A lab study found step counts collapse when walking is slow.
An umbrella review of 42 reviews found only two wearable measures — heart rate and atrial fibrillation — with comparably strong support. Getting any device into a trial is harder than buying it.
Smart-ring studies report flagging COVID nearly three days before symptoms and IBD flares weeks ahead. But two-thirds of that research carries a high risk of bias, and clinical usefulness is largely unproven.
Pooled against the sleep lab, finger-worn devices call sleep versus wake at 87% but fall to the mid-60s on light sleep. An Oura meta-analysis found no significant gap on total sleep time.
A network meta-analysis put pooled accuracy for the fertile window at 0.88, best in the three days around ovulation. A wrist-temperature study hit ovulation within three days about 78% of the time.
A February scientific statement declines to recommend the category for clinical decisions. Six weeks earlier, a journal retracted a validation study of a popular consumer model.
A review found wearables gave valid maximal-oxygen-uptake estimates in most studies of untrained and recreational exercisers. A separate meta-analysis pooled a 0.83 correlation, with high variability.
Against an ECG over 536 nights, Oura's heart-rate-variability error was under 8% and Whoop's acceptable, while Garmin and Polar lagged. The recovery scores layered on top stay proprietary and largely unvalidated.
A smartwatch bioimpedance sensor tracked body-fat percentage against DXA with about 14% average error — but muscle-mass agreement was weak, and even sitting versus standing shifted the reading.
A meta-analysis of 26 studies put pooled sensitivity at 95% and specificity at 97%. Samsung and Withings devices performed comparably to Apple — but the numbers come from people already suspected of arrhythmia.